IMPLANT SITE WARMTH

IMPLANT SITE WARMTH was reported 155 times

IMPLANT SITE WARMTH is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Progestin [EPC] 90 0.0003
2 gamma-Aminobutyric Acid-ergic Agonist [EPC] 22 0.0002
3 Androgen [EPC] 3 0.0001
4 Interleukin-31 Receptor alpha Antagonist [EPC] 1 0.0001
5 Cholinesterase Inhibitor [EPC] 1 0.0001
6 Alkaloid [EPC] 1 0.0000
7 Central alpha-2 Adrenergic Agonist [EPC] 2 0.0000
8 Amide Local Anesthetic [EPC] 3 0.0000
9 Provitamin D2 Compound [EPC] 1 0.0000
10 Nitroimidazole Antimicrobial [EPC] 2 0.0000
11 Penem Antibacterial [EPC] 1 0.0000
12 Mood Stabilizer [EPC] 6 0.0000
13 Opioid Agonist [EPC] 7 0.0000
14 Aminoglycoside Antibacterial [EPC] 1 0.0000
15 Ester Local Anesthetic [EPC] 1 0.0000
16 Complement Inhibitor [EPC] 1 0.0000
17 Cholinergic Nicotinic Agonist [EPC] 1 0.0000
18 Interferon beta [EPC] 3 0.0000
19 Leukocyte Growth Factor [EPC] 2 0.0000
20 Osmotic Laxative [EPC] 4 0.0000
21 Non-Standardized Chemical Allergen [EPC] 1 0.0000
22 Catecholamine [EPC] 1 0.0000
23 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
24 Acetylcholine Release Inhibitor [EPC] 1 0.0000
25 Antiarrhythmic [EPC] 1 0.0000
26 Expectorant [EPC] 2 0.0000
27 Anti-epileptic Agent [EPC] 2 0.0000
28 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
29 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
30 beta-Adrenergic Blocker [EPC] 2 0.0000
31 Aldosterone Antagonist [EPC] 1 0.0000
32 Azole Antifungal [EPC] 1 0.0000
33 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 7 0.0000
35 Thiazide Diuretic [EPC] 1 0.0000
36 Benzodiazepine [EPC] 3 0.0000
37 Platinum-based Drug [EPC] 1 0.0000
38 Platelet Aggregation Inhibitor [EPC] 2 0.0000
39 Corticosteroid [EPC] 4 0.0000
40 Vitamin B12 [EPC] 1 0.0000
41 Loop Diuretic [EPC] 1 0.0000